Project Grant R21EY036599
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$202K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Norman, OK 73019, USA
Similar Awards
This $488,639 Project Grant award, issued by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867), aims to identify the mechanisms underlying the enhanced virulence of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa causing a recent outbreak of keratitis. The research objectives are to systematically test the virulence factors of this new P. aeruginosa strain and to develop more effective ocular antibiotic formulations for treating...
This $425,000 federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development and validation of a rapid, culture-independent precision diagnostic approach for detecting pathogens and predicting antimicrobial resistance in sight-threatening ocular infections. The award aims to create a point-of-care metagenomics-based diagnostic tool that can transform ocular infection diagnosis and treatment from an empirical to a more...
This federal Project Grant award of $1,083,078 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research on the role of monocytes and neutrophils in fungal keratitis, a major cause of corneal blindness and vision loss. The funded project aims to examine: 1) the effect of monocyte depletion on neutrophil pro-inflammatory and fungal killing activity in the cornea, 2) the role of ICAM-1+ neutrophils and the HV1 proton channel in fungal keratitis, and 3)...
This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $204,875 to Clemson University to research the use of thymosin beta-4 as a novel treatment for Acanthamoeba keratitis, a serious eye infection that can lead to vision loss and blindness. The research aims to evaluate the efficacy of thymosin beta-4 in inhibiting the Acanthamoeba parasite and reducing associated inflammation and tissue damage in in vitro cell culture models and innovative ex vivo...
The National Eye Institute (NEI) awarded a 4-year, $1,313,945 Project Grant (CFDA 93.867 - Vision Research) to the University of Arizona to develop a long-acting topical nanomedicine therapy for the treatment of ocular herpes simplex virus (HSV) infections. The project aims to repurpose and reformulate the drug adefovir dipivoxil (ADV) to improve its topical delivery and reduce dosing frequency compared to currently approved treatments. Key objectives include evaluating ADV solution versus...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $617,323 in funding to the University of Notre Dame to develop selective inhibitors of the GRP94 protein as a new therapeutic approach for treating ocular hypertension and glaucoma. The key goals are to optimize the lead inhibitor compounds, determine their mechanism of action, and generate additional data to support their development as topically administered...
This Project Grant award from the National Eye Institute (NEI), under CFDA program 93.867 Vision Research, provides $974,348 to Wayne State University to conduct research on identifying metabolic biomarkers for diagnosing and treating infectious endophthalmitis. The primary objectives are to: Perform untargeted metabolomics analysis on vitreous samples from patients with culture-positive bacterial and fungal endophthalmitis (Aim 1). Develop an artificial intelligence model to predict...
The National Eye Institute (NEI) awarded a $1,018,210 Project Grant (CFDA 93.867 - Vision Research) to The Regents of the University of California, San Francisco (UCSF) to conduct a multi-year (Jul 2024 - Jun 2029) research project titled "Multi-Omics Strategies to Improve Clinical Outcomes in Uveitis". The key objectives are to: 1) perform worldwide surveillance of pathogens causing uveitis, identify geographic trends, and assess the impact of pathogens and antimicrobial resistance on...
The National Eye Institute (NEI) awarded a $441,250 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Washington to support a research project titled "Photoreceptor Induction in Wounded Corneas". The research aims to investigate how light modulates corneal wound healing through an opsin-dependent mechanism, with the goal of developing therapeutic approaches to facilitate wound closure and prevent scarring. The project will utilize in...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will support research on the role of the optineurin (OPTN) gene in herpes simplex virus type-1 (HSV-1) infection and its impact on corneal health and sensory nerve function. The $637,333 award, with a project period from March 1, 2025 to February 28, 2029, will fund comprehensive in vitro and in vivo studies to investigate the molecular mechanisms by which OPTN regulates...